Valencia Nutrition Limited , a company listed on the Bombay Stock Exchange (BSE), has successfully completed a preferential issue of equity shares. The company's Board of Directors has approved the allotment of 2,50,000 equity shares at Rs. 54.00 per share, which includes a premium of Rs. 44.00 per share.

Key Details of the Preferential Issue

Allotment Details

The 2,50,000 equity shares were allotted to two investors:

1. Anakin Ventures: 1,50,000 shares
2. Mr. Panthagani John Michael: 1,00,000 shares

Valencia Nutrition has confirmed that it received in-principle approval from the BSE for this preferential issue.

Implications for Investors

This allotment of shares indicates Valencia Nutrition's ability to attract investment and strengthen its capital base. The raised amount of Rs. 1.35 crore could potentially be used for various purposes as determined by the company.

The completion of this preferential issue may lead to changes in the company's shareholding pattern and could impact stock liquidity. Existing shareholders and potential investors may want to take note of this development.

As Valencia Nutrition moves forward with this capital infusion, market participants may be interested in how the company utilizes the funds and any subsequent impact on its business operations and financial performance.

Investors may wish to monitor further announcements from the company regarding the utilization of these funds and any resulting strategic initiatives.

Valencia Nutrition Limited has announced its unaudited financial results for the half-year ended September 30, 2025, showcasing a significant turnaround in its financial performance.

Financial Highlights

The company reported a profit of Rs. 59.30 lakhs for the period, marking a substantial improvement from the loss of Rs. 2.83 lakhs in the corresponding period of the previous year. This positive shift in profitability demonstrates the company's effective strategies and operational improvements.

Revenue from operations stood at Rs. 361.65 lakhs, compared to Rs. 154.55 lakhs in the prior year period, representing a robust growth of approximately 134%.

Key Financial Metrics

All figures in Rs. lakhs, except for Earnings Per Share

Operational Highlights

The company's Board of Directors approved both standalone and consolidated financial results in their meeting held on November 13, 2025. The statutory auditors issued an unmodified opinion on the financial statements, indicating compliance with accounting standards and regulations.

Valencia Nutrition operates in multiple segments, with its beverage segment contributing significantly to the overall revenue. The company's diversified product portfolio appears to be a key factor in its improved financial performance.

Utilization of Funds

Valencia Nutrition has been utilizing funds raised through a previous preferential allotment for various strategic initiatives:

1. Setting up Manufacturing Unit
2. Development & Launch of New Products
3. Marketing of Existing and New Products
4. Valencia Online Platform
5. General Corporate Purposes

As of September 30, 2025, the company has utilized Rs. 77,960,123 out of the total funds raised, with a balance of Rs. 534,417.80 remaining.

Future Outlook

While the company has not provided specific forward-looking statements, the significant improvement in financial performance and ongoing investments in manufacturing and product development suggest a positive trajectory for Valencia Nutrition Limited.

Investors and stakeholders will likely be watching closely to see if the company can maintain this momentum in the coming quarters and translate its investments into sustained growth and profitability.